Pad Chivukula - Sep 1, 2021 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role: Chief Scientific Officer & COO
Signature: /s/ Ilan Katz, attorney-in-fact
Stock symbol: ARCT
Transactions as of: Sep 1, 2021
Transactions value $: -$558,600
Form type: 4
Date filed: 9/2/2021, 09:06 PM
Previous filing: Aug 5, 2021
Next filing: Nov 3, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARCT	Common Stock	Sale	-$559K	-10K	-1.56%	$55.86	633K	Sep 1, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on September 1, 2021 with sale prices ranging from $53.91 to $57.26 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Content

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on September 1, 2021 with sale prices ranging from $53.91 to $57.26 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.